-
'1 Executive Summary
-
Market Introduction
-
Scope of Study
-
Research Objective 16
-
List of Assumptions 17
-
Research
-
process
-
Research Process 18
-
Primary Research 19
-
Secondary
-
Research 20
-
Market Size Estimation 21
-
Market Dynamics
-
Introduction
-
Drivers 22
- Increasing Geriatric Population 22
-
Increasing Adoption of Unhealthy Lifestyle 23
-
Popularity of Over-the-Counter
-
(OTC) Drugs 23
-
Restraints 23
-
High Cost of Diagnostics and Surgeries
-
Stringent Government Regulations 23
-
Opportunities 24
-
Entering Untapped Markets 24
-
Market Factor Analysis
-
Value Chain
-
Analysis 25
-
R&D and Product Development 25
- Manufacturing
- Distribution & Sales 26
- Post-Sales Monitoring 26
-
Porter’s Five Forces Analysis 27
- Bargaining Power of Suppliers
- Bargaining Power of Buyers 28
- Threat of New Entrants 28
- Threat of Substitutes 28
- Intensity of Rivalry 28
-
Investment
-
Opportunity Analysis 29
-
Global Carotid Artery Disease Market by Treatment
-
& Diagnosis
-
Introduction 30
-
Treatment 33
-
Diagnosis
-
Global Carotid Artery Disease Market by End User
-
Introduction
-
Hospital & Clinics 36
-
Ambulatory Surgical Centers 37
-
Pharmacies 37
-
Global Carotid Artery Disease Market by Region
-
Introduction 38
-
Americas 39
- North America 43
- South America 51
-
Europe 54
-
Western Europe 57
-
Germany 60
- UK 62
- Eastern Europe 75
-
Asia-Pacific 78
- Japan 81
- China 83
- India 86
- Australia 88
- South Korea
- Rest of Asia-Pacific 93
-
Middle East & Africa 96
-
Middle East 99
-
Africa 102
-
Competitive Landscape
-
Introduction
-
Key developments 106
-
Company Profiles
-
W. L. Gore
-
& Associates, Inc. 109
-
Company Overview 109
- Financial
-
Overview 109
-
Products/Services Offered 109
- Key Developments
- SWOT Analysis 110
- Key Strategies 110
-
Becton,
-
Dickinson and Company 111
-
Company Overview 111
- Financial
-
Overview 111
-
Products/Services Offered 111
- Key Developments
- SWOT Analysis 112
- Key Strategies 112
-
Terumo
-
Corporation 113
-
Company Overview 113
- Financial Overview
- Products/Services Offered 113
- Key Developments 114
- SWOT Analysis 114
- Key Strategies 114
-
Hitachi, Ltd
- Company Overview 115
- Financial Overview 115
-
Products/Services Offered 116
-
Key Developments 116
- SWOT
-
Analysis 116
-
Key Strategies 117
-
Silk Road Medical, Inc. 118
- Company Overview 118
- Financial Overview 118
- Products/Services
-
Offered 118
-
Key Developments 118
- SWOT Analysis 119
-
Key Strategies 119
-
Abbott 120
- Company Overview 120
-
Financial Overview 120
-
Products/Services Offered 121
- Key
-
Developments 121
-
SWOT Analysis 121
- Key Strategies 121
-
Medtronic 122
- Company Overview 122
- Financial Overview
- Products/Services Offered 123
- Key Developments 123
- SWOT Analysis 123
- Key Strategies 123
-
Stryker Corporation
- Company Overview 124
- Financial Overview 124
-
Products/Services Offered 125
-
Key Developments 125
- SWOT
-
Analysis 125
-
Key Strategies 125
-
Cardinal Health 126
-
Company Overview 126
-
Financial Overview 126
- Products/Services
-
Offered 127
-
Key Developments 127
- SWOT Analysis 127
-
Key Strategies 127
-
Boston Scientific Corporation 128
- Company
-
Overview 128
-
Financial Overview 128
- Products/Services
-
Offered 129
-
Key Developments 129
- SWOT Analysis 129
- Key Strategies 129
-
Appendix
-
References 130
-
Related Reports 130
-
List of Tables
-
BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 30
-
CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 31
-
GLOBAL CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 32
-
TREATMENT, BY REGION, 2020 TO 2027 (USD MILLION) 32
-
ARTERY DISEASE MARKET, FOR DIAGNOSIS, BY REGION, 2020 TO 2027 (USD MILLION) 33
-
BY REGION, 2020 TO 2027 (USD MILLION) 35
-
MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION,
-
TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 36
-
BY REGION, 2020 TO 2027 (USD MILLION) 37
-
DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 38
-
CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2020 TO 2027 (PROCEDURES) 39
-
AMERICAS: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO
-
(USD MILLION) 39
-
TREATMENT, 2020 TO 2027 (USD MILLION) 39
-
DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 40
-
CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
-
(USD MILLION) 41
-
REGION, 2020 TO 2027 (USD MILLION) 41
-
DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 42
-
NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD
-
MILLION) 42
-
TO 2027 (USD MILLION) 43
-
MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 43
-
AMERICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 44
-
TREATMENT, 2020 TO 2027 (USD MILLION) 45
-
MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 45
-
DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 46
-
US: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 46
-
TO 2027 (USD MILLION) 47
-
BY TREATMENT, 2020 TO 2027 (USD MILLION) 47
-
DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 48
-
CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
-
(USD MILLION) 49
-
TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 49
-
CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 50
-
SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD
-
MILLION) 50
-
PROCEDURE, 2020 TO 2027 (USD MILLION) 51
-
DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 51
-
CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 52
-
EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2020 TO 2027 (PROCEDURES)
-
TO 2027 (USD MILLION) 53
-
BY TREATMENT, 2020 TO 2027 (USD MILLION) 53
-
DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 53
-
CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
-
(USD MILLION) 54
-
REGION, 2020 TO 2027 (USD MILLION) 55
-
DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 56
-
WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD
-
MILLION) 56
-
TO 2027 (USD MILLION) 56
-
MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 57
-
EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 57
-
TO 2027 (USD MILLION) 58
-
BY TREATMENT, 2020 TO 2027 (USD MILLION) 58
-
DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 59
-
CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
-
(USD MILLION) 60
-
DIAGNOSIS, 2020 TO 2027 (USD MILLION) 60
-
MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 61
-
DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 61
-
ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 62
-
UK: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 62
-
TO 2027 (USD MILLION) 63
-
BY TREATMENT, 2020 TO 2027 (USD MILLION) 63
-
DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 64
-
CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
-
(USD MILLION) 65
-
& DIAGNOSIS, 2020 TO 2027 (USD MILLION) 65
-
DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 66
-
CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 66
-
ITALY: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD
-
MILLION) 67
-
TO 2027 (USD MILLION) 67
-
TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 68
-
ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 68
-
SPAIN: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 69
-
END USER, 2020 TO 2027 (USD MILLION) 70
-
ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS,
-
TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 71
-
DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 71
-
OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO
-
(USD MILLION) 72
-
MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 72
-
CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 73
-
BY MEDICATION, 2020 TO 2027 (USD MILLION) 74
-
ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 74
-
EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD
-
MILLION) 75
-
TO 2027 (USD MILLION) 76
-
MARKET, BY SURGERY, 2020 TO 2027 (PROCEDURES) 76
-
ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 77
-
BY MEDICATION, 2020 TO 2027 (USD MILLION) 77
-
ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 77
-
ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 79
-
BY TREATMENT, 2020 TO 2027 (USD MILLION) 79
-
DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 80
-
CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
-
(USD MILLION) 81
-
& DIAGNOSIS, 2020 TO 2027 (USD MILLION) 81
-
DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 82
-
CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 82
-
CHINA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD
-
MILLION) 83
-
TO 2027 (USD MILLION) 83
-
TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 84
-
ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 84
-
INDIA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 85
-
END USER, 2020 TO 2027 (USD MILLION) 86
-
DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 86
-
AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 87
-
BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 88
-
ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 88
-
SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO
-
(USD MILLION) 89
-
BY TREATMENT, 2020 TO 2027 (USD MILLION) 89
-
ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 90
-
SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027
-
(USD MILLION) 90
-
USER, 2020 TO 2027 (USD MILLION) 91
-
ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 92
-
DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 92
-
OF ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027
-
(USD MILLION) 93
-
BY END USER, 2020 TO 2027 (USD MILLION) 93
-
CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 94
-
MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2020 TO
-
(PROCEDURE) 94
-
MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 95
-
MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027
-
(USD MILLION) 95
-
MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 96
-
& AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027
-
(USD MILLION) 96
-
MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 97
-
ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 98
-
BY MEDICATION, 2020 TO 2027 (USD MILLION) 98
-
ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 99
-
MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION)
-
TO 2027 (USD MILLION) 100
-
BY TREATMENT, 2020 TO 2027 (USD MILLION) 100
-
DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 101
-
CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
-
(USD MILLION) 102
-
DISEASE MARKET 103
-
List of Figures
-
ARTERY DISEASE MARKET: STRUCTURE 16
-
TOP-DOWN AND BOTTOM-UP APPROACHES 20
-
THE CAROTID ARTERY DISEASE MARKET 21
-
CAROTID ARTERY DISEASE MARKET 24
-
GLOBAL CAROTID ARTERY DISEASE MARKET 26
-
MARKET, BY TREATMENT & DIAGNOSIS, 2020 & 2027 (USD MILLION) 30
-
GLOBAL CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 & 2027 (USD MILLION)
-
BY REGION, 2020 (%) 55
-
SHARE, BY REGION, 2020 (%) 76
-
DISEASE MARKET SHARE, BY REGION, 2020 (%) 94
-
OF KEY DEVELOPMENTS 106'